-
CG13645 encodes Drosophila Nmnat (dNmnat), a bona fide nicotinamide mononucleotide
adenylyltransferase. Recombinant dNmnat has NMNAT activity comparable to human NMNAT3,
and mutations in conserved catalytic/substrate-binding residues sharply reduce activity,
confirming its enzymatic identity within the eukaryotic NMNAT family.
"recombinant dNmnat protein exhibits NMNAT activity comparable to human NMNAT3 in an in vitro coupled assay, and mutations in conserved catalytic/substrate-binding motifs sharply reduce enzymatic activity, confirming that CG13645 encodes a bona fide NMNAT enzyme."
-
NMNAT enzymes catalyze NMN + ATP -> NAD+ + PPi, placing dNmnat in the NAD+ salvage axis;
the mutation-activity relationships support that its primary biochemical role is NMN
adenylyltransferase activity in NAD+ biosynthesis/salvage.
"these mutation–activity relationships experimentally support that the enzyme’s primary biochemical role is NMN adenylyltransferase activity in NAD\(^+\) biosynthesis/salvage."
-
dNmnat's neuroprotective/maintenance function is partially uncoupled from its NAD+-synthesis
activity: catalytically impaired mutants retaining <1% activity (e.g., WR) still strongly
rescue neurodegeneration in vivo, including photoreceptor maintenance. The neuroprotective
role is a genuine function, not an over-annotation.
"A central, well-cited observation in *Drosophila* is that dNmnat’s **neuroprotective/maintenance function can be partially uncoupled from its NAD\(^+\)-synthesis activity**. Catalytically impaired mutants that retain <1% enzymatic activity (e.g., WR) can still strongly rescue neurodegeneration phenotypes in vivo (e.g., photoreceptor maintenance)"
-
dNmnat/NMNAT acts as a chaperone-like protector in proteotoxic contexts: it binds misfolded
species (e.g., Tau oligomers), promotes their ubiquitination/clearance, and its loss
exacerbates Tau-induced degeneration while its expression suppresses degeneration in
Drosophila models. This supports a moonlighting proteostasis/chaperone function.
"dNmnat/NMNAT is described as binding misfolded species (e.g., Tau oligomers), promoting their ubiquitination/clearance, and that reduced endogenous NMNAT exacerbates Tau-induced degeneration, while NMNAT expression suppresses degeneration in Drosophila models."
-
dNmnat localizes to neuronal nuclei (brain and ventral nerve cord, persisting into
adulthood) and to punctate synaptic/terminal structures partially colocalizing with the
active-zone marker nc82, including photoreceptor terminals of the adult lamina; it is also
detected in muscle nuclei.
"- **Abundant in neuronal nuclei** (brain and ventral nerve cord), persisting into adulthood. (zhai2006drosophilanmnatmaintains pages 5-7)
- Present as **punctate labeling at synapses/terminals**, partially colocalizing with the active zone marker nc82, including in photoreceptor terminals of the adult lamina. (zhai2006drosophilanmnatmaintains pages 5-7)
- Also detected strongly in **muscle nuclei**, and pan-neuronal expression alone does not rescue lethality, implying important extra-neuronal requirements."
-
dNmnat is essential for axonal integrity in vivo: depletion causes spontaneous retrograde
("dying-back") degeneration in the wing nerve and Wallerian-like fragmentation of severed
axons, while dNmnat upregulation preserves injured axons and their mitochondria.
"depletion/knockdown of endogenous dNmnat induces spontaneous retrograde (“dying back”) degeneration in the wing nerve, and severed axons show Wallerian-like fragmentation scored on a 0–4 scale."
-
Modern pathway models place NMNAT/dNmnat as an axon survival factor antagonizing programmed
axon degeneration; falling NMNAT activity and a rising NMN/NAD+ ratio activate SARM1/dSarm,
an NADase that depletes NAD+ and drives degeneration.
"NMNAT activity supports axon survival, while SARM1/dSarm is an NADase whose activation drives NAD loss and degeneration."